发明名称 |
ANTIKÖRPER, DER DAS GM1-GANGLIOSID-GEBUNDENE AMYLOID-b-PROTEIN ERKENNT, UND DNA, DIE FÜR DIESEN ANTIKÖRPER CODIERT |
摘要 |
It is intended to provide an antibody efficacious in diagnosing, preventing or treating Alzheimer's disease, DNA encoding the antibody, a method of screening a drug and drugs. The amino acid sequence and the gene sequence of the variable region of an antibody, which specifically recognizes a GM1 ganglioside-bound amyloid beta -protein occurring in the early stage of beta -amyloid fibril formation, are determined. Based on the data of the amino acid sequence and the gene sequence thus obtained, an antibody is designed. |
申请公布号 |
DE60226036(T2) |
申请公布日期 |
2009.06.25 |
申请号 |
DE2002626036T |
申请日期 |
2002.08.01 |
申请人 |
Medical & Biological Laboratories Co., Ltd.;Japan as represented by the Director of Chubu National Hospital;Yanagisawa, Katsuhiko |
发明人 |
YANAGISAWA, Katsuhiko;SHIBATA, Masao |
分类号 |
C07K16/18;A61K39/395;C12N5/16;C12N15/13;C12N15/85;C12P21/08 |
主分类号 |
C07K16/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|